These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35768298)

  • 1. Prognostic Factors Evaluation for Liver Transplant Mismatching: A New Way of Selecting and Allocating Organs.
    Nacif LS; Zanini LYK; Fernandes MR; Pinheiro RS; Rocha-Santos V; De Martino RB; Waisberg DR; Macedo RA; Ducatti L; Haddad L; Galvão FHF; Andraus W; Carneiro-D'Albuquerque L
    Transplant Proc; 2022 Jun; 54(5):1295-1299. PubMed ID: 35768298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
    Geyer ED; Burrier C; Tumin D; Hayes D; Black SM; Washburn WK; Tobias JD
    Transpl Int; 2018 Nov; 31(11):1200-1206. PubMed ID: 29907976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting survival after living and deceased donor liver transplantation in adult patients with acute liver failure.
    Jin YJ; Lim YS; Han S; Lee HC; Hwang S; Lee SG
    J Gastroenterol; 2012 Oct; 47(10):1115-24. PubMed ID: 22526269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry.
    Kim JM; Kim DG; Kim J; Lee K; Lee KW; Ryu JH; Kim BW; Choi DL; You YK; Kim DS; Nah YW; Kang KJ; Cho JY; Hong G; Yu HC; Moon JI; Choi D; Hwang S; Kim MS
    Clin Mol Hepatol; 2021 Jul; 27(3):451-462. PubMed ID: 33525077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.
    Gan K; Li Z; Bao S; Fang Y; Wang T; Jin L; Ma M; Deng L; Peng Y; Li N; Zeng Z; Huang H
    Transpl Immunol; 2021 Dec; 69():101476. PubMed ID: 34601097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
    Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Surgical Complications but Improved Overall Survival with Adult Living Donor Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis.
    Tang W; Qiu JG; Cai Y; Cheng L; Du CY
    Biomed Res Int; 2020; 2020():1320830. PubMed ID: 32908865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Survival Following Living Donor Liver Transplantation for Pediatric Acute Liver Failure: Analysis of 20 Years of US National Registry Data.
    Firl DJ; Sasaki K; McVey J; Hupertz V; Radhakrishnan K; Fujiki M; Eghtesad B; Miller CM; Quintini C; Hashimoto K
    Liver Transpl; 2019 Aug; 25(8):1241-1250. PubMed ID: 31119826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Pediatric Liver Transplantation in Japan: A Report from the Registry of the Japanese Liver Transplantation Society.
    Kasahara M; Umeshita K; Eguchi S; Eguchi H; Sakamoto S; Fukuda A; Egawa H; Haga H; Kokudo N; Sakisaka S; Takada Y; Tanaka E; Uemoto S; Ohdan H
    Transplantation; 2021 Dec; 105(12):2587-2595. PubMed ID: 33982916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Predictive Ability of the Glasgow Prognostic Score and Variants in Both Deceased Donor and Living Donor Liver Transplantation for Hepatocellular Cancer.
    Agalar C; Egeli T; Unek T; Ozbilgin M; Aysal A; Cevlik AD; Sagol O; Bacakoglu A; Ellidokuz H; Astarcioglu I
    Transplant Proc; 2019 May; 51(4):1134-1138. PubMed ID: 31101186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better Selection Criteria With Prognostic Factors for Liver Transplantation.
    Nacif LS; Pinheiro RS; Rocha-Santos V; Barbosa VM; de Moura Dias AP; Martino RB; Macedo RA; Ducatti L; Haddad L; Galvão F; Andraus W; Carneiro D' Albuquerque L
    Transplant Proc; 2018 Apr; 50(3):766-768. PubMed ID: 29661433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor-dominant program.
    Kasahara M; Katono M; Schlegel A; Kubota T; Nakazato Y; Uchida H; Shimizu S; Yanagi Y; Takeda M; Fukuda A; Sakamoto S
    Pediatr Transplant; 2019 Dec; 23(8):e13578. PubMed ID: 31535772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does living donation have advantages over deceased donation in liver transplantation?
    Kaido T; Uemoto S
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1598-603. PubMed ID: 20880167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients: A Systematic Review and Meta-analysis.
    Shingina A; Vutien P; Uleryk E; Shah PS; Renner E; Bhat M; Tinmouth J; Kim J
    Liver Transpl; 2022 Mar; 28(3):437-453. PubMed ID: 34331391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
    Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
    Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.